Reynold Lemkins Drives Cross-Border Deep Tech Investment, Featured Prominently at Asia’s Leading Capital and Innovation Forums

Audio By Carbonatix

HONG KONG & MACAU--(BUSINESS WIRE)--Aug 4, 2025--

Reynold Lemkins Group, a global investment firm known for its long-term cross-border capital strategy, made a notable impact this May at two of Asia’s premier events: the Greenwich Economic Forum (GEF) Hong Kong and BEYOND Expo 2025 in Macau.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804494130/en/

Reynold Lemkins at the Greenwich Economic Forum Hong Kong

At GEF Hong Kong, Reynold Lemkins Asia Chief Investment Officer Kris Haoran Liu was invited to speak on a high-level roundtable titled “Family Office Investment Outlook”, moderated by Tae Yoo, Managing Director of Hong Kong Exchanges and Clearing (HKEX). Liu emphasized IPO as not merely an exit but a strategic entry point into long-term value creation, especially in sectors undergoing structural transformation. He also highlighted Hong Kong’s pivotal role as a pricing anchor for global capital.

The forum, which brought together global financial leaders including Nouriel Roubini (Chairman & CEO, Roubini Macro Associates), Kenny Lam (CEO, Two Sigma Asia Pacific), and Jan Boomaars (CEO, Optiver), underscored the rising relevance of Asia—especially Hong Kong—in the evolving landscape of alternative investments, economic realignment, and tech-led growth.

In Macau, at BEYOND Expo 2025 —Asia’s largest tech innovation summit—Reynold Lemkins took part as a Legacy Partner, hosting private sessions with deep tech founders, researchers, and institutional LPs. The firm engaged across verticals including AI, advanced manufacturing, robotics, and frontier healthtech, reinforcing its thesis of value-backed, scalable innovation across borders.

“Reynold Lemkins Group demonstrated clear conviction in identifying globally relevant tech solutions, from regulatory-ready biotech platforms to next-gen energy systems and smart infrastructure,” commented a tech investor familiar with the firm’s presence in Macau.

Recent investments reflect this diversified thesis. In addition to health-focused companies like Cloudbreak Pharma and VISEN Pharmaceuticals, the firm has also actively supported high-growth industrial and AI ventures such as Contemporary Amperex Technology (CATL), Sanhua Intelligent Controls, and Unisound, exemplifying its multi-sector strategy across late-stage and semi-public market opportunities.

To learn more, visit www.reynoldlemkins.com, follow Reynold Lemkins on LinkedIn, or explore insights via Medium.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250804494130/en/

CONTACT: Reynold Lemkins Group

[email protected]

KEYWORD: NORTH AMERICA UNITED STATES ASIA PACIFIC CHINA HONG KONG CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY FINANCE PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH ROBOTICS PHARMACEUTICAL ASSET MANAGEMENT ARTIFICIAL INTELLIGENCE

SOURCE: Reynold Lemkins Group

Copyright Business Wire 2025.

PUB: 08/04/2025 08:20 PM/DISC: 08/04/2025 08:22 PM

http://www.businesswire.com/news/home/20250804494130/en